Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd. Provides Earnings Guidance for the Full Year of 2018
Hangzhou TianMuShan Pharmaceutical Enterprise Co. Ltd. provided earnings guidance for the full year of 2018. The company predicts a decrease of between RMB 15,141,600 and RMB 17,641,600 in its net profit owned by shareholders of the company in 2018 compared with the same period of the year before, with a year-on-year decrease of between 185.98% and 216.69%. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will be between negative of RMB 26,293,700 and RMB 23,793,700.